|
While
we recognize the important role the pharmaceutical industry plays in medicine,
at MD Conferences we maintain a policy of neither soliciting nor accepting
any funding for expenses, administration costs, production of materials,
or for any other purposes from the pharmaceutical industry.
Why
do we feel so strongly about this? As CME providers, we feel we should
be held to a higher standard regarding pharmaceutical funding support
than is currently the practice in medical education. CME providers have
the potential to effect practice patterns of our colleagues in medicine,
and the potential conflict of interest between educators and the therapeutics
they teach is obvious, especially if there is financial dependence upon
corporate groups with an interest in the very therapeutics being taught.
An
all too common response to this issue in many (most!) CME settings, large
and small, is to increase the dependence on pharmaceutical funding by
soliciting funding from many different pharmaceutical corporations. The
underlying assumption is that a long list of corporate sponsors obviates
potential conflict or bias. At MD Conferences, we prefer a simpler approach....to
simply accept no pharmaceutical funding whatsoever.
|